Close

Double your impact Match My Donation

Immunotherapy By Cancer Type

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
Impacting All Cancers

From the preventive vaccine for cervical cancer to the first therapy ever proven to extend the lives of patients with metastatic melanoma, immunology has already led to major treatment breakthroughs for a number of cancers. Every cancer type is unique, though, and immunology and immunotherapy are impacting each cancer in different ways.

Bladder Cancer
The first FDA-approved immunotherapy treatment—Bacillus Calmette-Guérin cancer vaccine—was for bladder cancer in 1990.
Brain Cancer
Cancers of the brain and nervous system are relatively rare but very serious. Immunotherapy is showing significant promise where other approaches have failed.
Breast Cancer
New studies of immunotherapy in the treatment of breast cancer, one of the most commonly diagnosed cancer types among women globally, are encouraging, with the potential for long-term success.
Cervical Cancer
By far, the most significant cause of cervical cancer, as well as other ano-genital cancers, is infection with a virus—the human papillomavirus (HPV).
Childhood Cancer
Immunotherapy offers a potential way to treat childhood (pediatric) cancer without the damaging, long-term side effects of conventional treatments.
Colorectal Cancer
There are several FDA-approved immunotherapies for colorectal cancer, for which patients are in urgent need of new treatment options.
Esophageal Cancer
There are two main types of esophageal cancer: squamous cell carcinoma and adenocarcinoma.
Head and Neck Cancer
While many different types of cancer can occur in the head and neck, squamous cell carcinoma in the most common cancer of the head and neck.
Kidney Cancer
About 9 out of every 10 kidney cancers are renal cell carcinomas—cancers that form in the lining of the tubules inside the kidney.
Leukemia
There are several FDA-approved immunotherapy treatments for leukemia (leukaemia) and ongoing research demonstrates even greater potential for new treatments.
Liver Cancer
Immunotherapy treatments can enhance the immune system’s response to liver cancer but may not always be viable for patients with a history of hepatitis infection.
Lung Cancer
Immunotherapy is a promising treatment option for advanced lung cancer, alone or in combination with conventional treatments like chemotherapy or surgery.
Lymphoma
Lymphoma is the name for a group of blood cancers that develop in certain immune cells. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL).
Melanoma
The future of melanoma treatment is evolving, thanks to the revolutionary advancements in immunotherapy for skin cancers.
Multiple Myeloma
Myeloma—also referred to as multiple myeloma or plasma cell myeloma—is a cancer that originates in plasma cells, a type of white blood cell that make antibodies.
Ovarian Cancer
Research into immunotherapy for ovarian cancer is promising, especially since more treatment options for patients and oncologists are urgently needed.
Pancreatic Cancer
Pancreatic cancer has few treatment options, so pancreatic cancer immunotherapy research is vital to providing patients with new hope.
Prostate Cancer
Prostate cancer is the second most common cancer in men worldwide, and the eighth leading cause of cancer-related death.
Sarcoma
Sarcoma is a rare cancer in adults (1% of all adult cancers), but rather prevalent in children (about 15% of all childhood cancers).
Skin Cancer
Skin cancers are common, often diagnosed at an early stage, and among the first cancers to respond to immunotherapy
Stomach Cancer
Stomach cancer is the fifth most common diagnosis in cancer, and it is the third most deadly, with nearly 725,000 deaths.

*Immunotherapy results may vary from patient to patient.

Top